These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 28398653

  • 1. The noble gas xenon provides protection and trophic stimulation to midbrain dopamine neurons.
    Lavaur J, Le Nogue D, Lemaire M, Pype J, Farjot G, Hirsch EC, Michel PP.
    J Neurochem; 2017 Jul; 142(1):14-28. PubMed ID: 28398653
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases.
    Le Nogue D, Lavaur J, Milet A, Ramirez-Gil JF, Katz I, Lemaire M, Farjot G, Hirsch EC, Michel PP.
    J Neural Transm (Vienna); 2020 Jan; 127(1):27-34. PubMed ID: 31807953
    [Abstract] [Full Text] [Related]

  • 3. Effects of xenon on in vitro and in vivo models of neuronal injury.
    Wilhelm S, Ma D, Maze M, Franks NP.
    Anesthesiology; 2002 Jun; 96(6):1485-91. PubMed ID: 12170064
    [Abstract] [Full Text] [Related]

  • 4. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
    Banks P, Franks NP, Dickinson R.
    Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site.
    Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R.
    Anesthesiology; 2013 Nov; 119(5):1137-48. PubMed ID: 23867231
    [Abstract] [Full Text] [Related]

  • 6. The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotine.
    Guerreiro S, Florence C, Rousseau E, Hamadat S, Hirsch EC, Michel PP.
    Mol Pharmacol; 2015 Nov; 87(3):525-32. PubMed ID: 25552485
    [Abstract] [Full Text] [Related]

  • 7. Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction.
    Nafia I, Re DB, Masmejean F, Melon C, Kachidian P, Kerkerian-Le Goff L, Nieoullon A, Had-Aissouni L.
    J Neurochem; 2008 Apr; 105(2):484-96. PubMed ID: 18042178
    [Abstract] [Full Text] [Related]

  • 8. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia.
    Dingley J, Tooley J, Porter H, Thoresen M.
    Stroke; 2006 Feb; 37(2):501-6. PubMed ID: 16373643
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective and neurorestorative potential of xenon.
    Lavaur J, Lemaire M, Pype J, Le Nogue D, Hirsch EC, Michel PP.
    Cell Death Dis; 2016 Apr 07; 7(4):e2182. PubMed ID: 27054337
    [No Abstract] [Full Text] [Related]

  • 10. Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stress.
    Lavaur J, Lemaire M, Pype J, Le Nogue D, Hirsch EC, Michel PP.
    Cell Death Discov; 2016 Apr 07; 2():16018. PubMed ID: 27551511
    [Abstract] [Full Text] [Related]

  • 11. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons.
    Ballaz S, Morales I, Rodríguez M, Obeso JA.
    J Neurosci Res; 2013 Dec 07; 91(12):1609-17. PubMed ID: 23996657
    [Abstract] [Full Text] [Related]

  • 12. Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons.
    Himi T, Ikeda M, Yasuhara T, Murota SI.
    J Neurosci Res; 2003 Mar 01; 71(5):679-88. PubMed ID: 12584726
    [Abstract] [Full Text] [Related]

  • 13. Reduction of ischemic brain damage by nitrous oxide and xenon.
    David HN, Leveille F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M, Abraini JH.
    J Cereb Blood Flow Metab; 2003 Oct 01; 23(10):1168-73. PubMed ID: 14526227
    [Abstract] [Full Text] [Related]

  • 14. Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes.
    Michel PP, Marien M, Ruberg M, Colpaert F, Agid Y.
    J Neurochem; 1999 May 01; 72(5):2074-82. PubMed ID: 10217287
    [Abstract] [Full Text] [Related]

  • 15. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN, Ansseau M, Lemaire M, Abraini JH.
    Biol Psychiatry; 2006 Jul 01; 60(1):49-57. PubMed ID: 16427030
    [Abstract] [Full Text] [Related]

  • 16. Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones.
    Dinse A, Föhr KJ, Georgieff M, Beyer C, Bulling A, Weigt HU.
    Br J Anaesth; 2005 Apr 01; 94(4):479-85. PubMed ID: 15695547
    [Abstract] [Full Text] [Related]

  • 17. Effect of xenon on excitatory and inhibitory transmission in rat spinal ventral horn neurons.
    Yamamoto T, Honda H, Baba H, Kohno T.
    Anesthesiology; 2012 May 01; 116(5):1025-34. PubMed ID: 22411062
    [Abstract] [Full Text] [Related]

  • 18. [Xenon - noble gas with organprotective properties].
    Preckel B, Weber N, Schlack W.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Aug 01; 39(8):456-62. PubMed ID: 15319839
    [Abstract] [Full Text] [Related]

  • 19. Protection of cultured dopamine neurons from MPP(+) requires a combination of neurotrophic factors.
    Jaumotte JD, Wyrostek SL, Zigmond MJ.
    Eur J Neurosci; 2016 Jul 01; 44(1):1691-9. PubMed ID: 27098376
    [Abstract] [Full Text] [Related]

  • 20. The neuroprotective effect and possible therapeutic application of xenon in neurological diseases.
    Zhang M, Cui Y, Cheng Y, Wang Q, Sun H.
    J Neurosci Res; 2021 Dec 01; 99(12):3274-3283. PubMed ID: 34716615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.